BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 22, 2025
Home
»
Authors
»
Jennifer Boggs
Articles by Jennifer Boggs
OpGen's New CEO Focusing On Optical Mapping Platform Growth
Jan. 4, 2005
By
Jennifer Boggs
ALZA Files For Approval Of Premature Ejaculation Drug
Dec. 29, 2004
By
Jennifer Boggs
ALZA Files For Approval Of Premature Ejaculation Drug
Dec. 29, 2004
By
Jennifer Boggs
Sunesis Planning For $86M IPO; Funds Partially For Clinical Trials
Dec. 28, 2004
By
Jennifer Boggs
Sunesis Planning For $86M IPO; Funds Partially For Clinical Trials
Dec. 28, 2004
By
Jennifer Boggs
Symbollon Beginning Phase III With Product For Breast Pain
Dec. 23, 2004
By
Jennifer Boggs
Symbollon Beginning Phase III With Product For Breast Pain
Dec. 23, 2004
By
Jennifer Boggs
Cell Therapeutics Raises $18.5M, Forms Quintiles Trisenox Deal
Dec. 22, 2004
By
Jennifer Boggs
Cell Therapeutics Raises $18.5M, Forms Quintiles Trisenox Deal
Dec. 22, 2004
By
Jennifer Boggs
Gilead, BMS Establish JV To Combine HIV Products
Dec. 21, 2004
By
Jennifer Boggs
Previous
1
2
…
321
322
323
324
325
326
327
328
329
Next